Patrick J. Heron, 10% Owner, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 2,406,271 shares at $19.00 ($40.6M) on 2019-10-29, disclosed to the SEC on 2019-10-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.20 | 1,353,640 | $20.6M | 50.7% |
| 2 | $19.00 | 1,052,631 | $20.0M | 49.3% |
| Total | $16.86 avg | 2,406,271 | $40.6M | 100% |
| Filing → |
| ARQT | BUY | 2025-06-06 | $30K | — | Filing → |
| ARQT | BUY | 2025-05-23 | $69K | — | Filing → |
| ARQT | BUY | 2025-05-19 | $34K | — | Filing → |